Wcn24-762 updated results from the ruby-3 study of povetacicept, an enhanced dual baff/april antagonist, in autoantibody-associated glomerulonephritis
Kidney International Reports(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Kidney International Reports(2024)